Autori: Seremetis S
| Naslov | Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (Article) |
| Autori | Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M  Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Seremetis S Lindblom A Santagostino E
|
| Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 698-705 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article) |
| Autori | Lentz SR Misgav M Ozelo MC Salek SZ Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Seremetis S Lindblom A Martinowitz U |
| Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
